Re-read your post from 14/03/2019 @hercules007 – and pleased to...

Re-read your post from 14/03/2019 @hercules007 – and pleased to see that we’re at a SP of $1.60 today – so it’s held up quite (very?) well over the week.

It seemed more than reasonable to expect some correction / consolidation / ST profit taking – but I am taking it as a healthy sign that the support is there at this level. PAR just feels solid in terms of potential.

Anyone else notice the $80K / 50,000 share trade on opening this morning? Someone is confident in where things may go in the near term. And someone else would have made a solid return regardless of when they were purchased. Still – a day is a long time riding the fickle beast that is the share market.

But I’m looking forward to that txt / e-mail arriving to let me know there is a price sensitive announcement - and not full of anxiety associated with binary outcomes so commonly typical around small cap biotechs.

The only decision left is how long to hang on for after that. So much news still to come – and all this recent growth has only seemingly made up the distance lost after the Phase 2 result.

Personally, I’m in until the IND in Q3/2019 as a minimum – and while initially was tempted to take some profit along the way – I’d hate to miss out along the way when this stock is so damn pregnant with news.